Chronic administration of anticholinergics in rats induces a shift from muscarinic to purinergic transmission in the bladder wall

European Urology

Volumn 64, Issue 3, 2013, Pages 502-510

  Uvin, Pieter ^a   Boudes, Mathieu ^a   Menigoz, Aurélie ^a   Franken, Jan ^a   Pinto, Sílvia ^a   Gevaert, Thomas ^a   Verplaetse, Ruth ^a   Tytgat, Jan ^a   Vennekens, Rudi ^a   Voets, Thomas ^a   De Ridder, Dirk ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Anticholinergics; Antimuscarinics; Fesoterodine; Muscarinic receptor; Oxybutynin; Purinergic receptor; Rats

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARBACHOL; FESOTERODINE; LIGAND GATED ION CHANNEL; MEMBRANE PROTEIN; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; OXYBUTYNIN; PURINERGIC P2X RECEPTOR; PURINERGIC RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER FUNCTION; BLADDER WALL; CATHETER; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CYSTOMETRY; DETRUSOR MUSCLE; DRUG EFFECT; DRUG MECHANISM; FEMALE; IMPLANTATION; MICTURITION; MUSCLE CONTRACTILITY; NONHUMAN; OSMOTIC PUMP; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT DURATION; URODYNAMICS; WESTERN BLOTTING;

ANTICHOLINERGICS; ANTIMUSCARINICS; FESOTERODINE; MUSCARINIC RECEPTOR; OXYBUTYNIN; PURINERGIC RECEPTOR; RATS;

ANIMALS; BENZHYDRYL COMPOUNDS; CHOLINERGIC AGONISTS; CHOLINERGIC ANTAGONISTS; CHOLINERGIC NEURONS; FEMALE; INFUSION PUMPS, IMPLANTABLE; MANDELIC ACIDS; MUSCLE CONTRACTION; PURINERGIC P2X RECEPTOR AGONISTS; PURINERGIC P2X RECEPTOR ANTAGONISTS; PURINES; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTORS, MUSCARINIC; RECEPTORS, PURINERGIC P2X1; SYNAPTIC TRANSMISSION; TIME FACTORS; URINARY BLADDER; URINARY CATHETERIZATION; URINATION; URODYNAMICS; UROLOGICAL AGENTS;

EID: 84881121817     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.05.031     Document Type: Article

References (31)

1. D.E. Irwin, L. Mungapen, I. Milsom, Z. Kopp, P. Reeves, and C. Kelleher The economic impact of overactive bladder syndrome in six Western countries BJU Int 103 2009 202 209
2. P. Abrams, and K.-E. Andersson Muscarinic receptor antagonists for overactive bladder BJU Int 100 2007 987 1006
3. S. De Wachter, and J.-J. Wyndaele Intravesical oxybutynin: A local anesthetic effect on bladder C afferents J Urol 169 2003 1892 1895
4. J. Yeaw, J.S. Benner, J.G. Walt, S. Sian, and D.B. Smith Comparing adherence and persistence across 6 chronic medication classes J Manag Care Pharm 15 2009 728 740
5. C.L.G. Sears, C. Lewis, K. Noel, T.S. Albright, and J.R. Fischer Overactive bladder medication adherence when medication is free to patients J Urol 183 2010 1077 1081
6. R. Dmochowski ACP Journal Club. Review: Drugs for urgency urinary incontinence improve continence in women Ann Intern Med 157 2012 JC4-4
7. K. Andersson, and A.J. Wein Pharmacology of the lower urinary tract: Basis for current and future treatments of urinary incontinence Pharmacol Rev 56 2004 581 631
8. L. Kasakov, and G. Burnstock The use of the slowly degradable analog, alpha, beta-methylene ATP, to produce desensitisation of the P2-purinoceptor: Effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder Eur J Pharmacol 86 1982 291 294
9. H.Y. Lee, M. Bardini, and G. Burnstock Distribution of P2X receptors in the urinary bladder and the ureter of the rat J Urol 163 2000 2002 2007
10. R.J. Theobald Purinergic and cholinergic components of bladder contractility and flow Life Sci 56 1995 445 454
11. G.N. Sibley A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit J Physiol 354 1984 431 443
12. K. Andersson, R. Soler, and C. Füllhase Rodent models for urodynamic investigation Neurourol Urodyn 30 2011 636 646
13. N. Haga, K. Aikawa, K. Shishido, N. Takahashi, T. Yanagida, and O. Yamaguchi Effect of long-term oxybutynin administration on c-Fos expression in spinal neurons: Inhibition of antimuscarinics on bladder afferents in conscious rats Urology 73 2009 200 204
14. M. Boudes, P. Uvin, S. Kerselaers, R. Vennekens, T. Voets, and D. De Ridder Functional characterization of a chronic cyclophosphamide-induced overactive bladder model in mice Neurourol Urodyn 30 2011 1659 1665
15. P. Uvin, W. Everaerts, and S. Pinto The use of cystometry in small rodents: A study of bladder chemosensation J Vis Exp 2012 e3869
16. T.P. Lockwich, X. Liu, B.B. Singh, J. Jadlowiec, S. Weiland, and I.S. Ambudkar Assembly of Trp1 in a signaling complex associated with caveolin-scaffolding lipid raft domains J Biol Chem 275 2000 11934 11942
17. T. Gevaert, J. Vriens, and A. Segal Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding J Clin Invest 117 2007 3453 3462
18. W. Everaerts, J. Vriens, and G. Owsianik Functional characterization of transient receptor potential channels in mouse urothelial cells Am J Physiol Renal Physiol 298 2010 F692 F701
19. M. Bayliss, C. Wu, D. Newgreen, A.R. Mundy, and C.H. Fry A quantitative study of atropine-resistant contractile responses in human detrusor smooth muscle, from stable, unstable and obstructed bladders J Urol 162 1999 1833 1839
20. W.D. Cowan, and E.E. Daniel Human female bladder and its noncholinergic contractile function Can J Physiol Pharmacol 61 1983 1236 1246
21. C. Sjögren, K.E. Andersson, S. Husted, A. Mattiasson, and B. Moller-Madsen Atropine resistance of transmurally stimulated isolated human bladder muscle J Urol 128 1982 1368 1371
22. R.B. Kinder, and A.R. Mundy Pathophysiology of idiopathic detrusor instability and detrusor hyper-reflexia. An in vitro study of human detrusor muscle Br J Urol 60 1987 509 515
23. T. Streng, A. Talo, and K.-E. Andersson Transmitters contributing to the voiding contraction in female rats BJU Int 94 2004 910 914
24. K.-E. Andersson, C.R. Chapple, and L. Cardozo Pharmacological treatment of overactive bladder: Report from the International Consultation on Incontinence Curr Opin Urol 19 2009 380 394
25. K. De Laet, S. De Wachter, and J.-J. Wyndaele Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: New insights into the working mechanism of antimuscarinics Neurourol Urodyn 25 2006 156 161
26. Y.E. Yarker, K.L. Goa, and A. Fitton Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability Drugs Aging 6 1995 243 262
27. B.A. O'Reilly, A.H. Kosaka, and G.F. Knight P2X receptors and their role in female idiopathic detrusor instability J Urol 167 2002 157 164
28. F.C.L. Banks, G.E. Knight, R.C. Calvert, R.J. Morgan, and G. Burnstock Alterations in purinergic and cholinergic components of contractile responses of isolated detrusor contraction in a rat model of partial bladder outlet obstruction BJU Int 97 2006 372 378
29. D. Giglio, and G. Tobin Muscarinic receptor subtypes in the lower urinary tract Pharmacology 83 2009 259 269
30. H.H. Lai, C.P. Smith, A. Munoz, T.B. Boone, G.P. Szigeti, and G.T. Somogyi Activation of cholinergic receptors blocks non-adrenergic non-cholinergic contractions in the rat urinary bladder Brain Res Bull 77 2008 420 426
31. D. Giglio, D.S. Delbro, and G. Tobin On the functional role of muscarinic M2 receptors in cholinergic and purinergic responses in the rat urinary bladder Eur J Pharmacol 428 2001 357 364